Preoperative CT not reliable for assessing tumor thickness in oral tongue squamous cell carcinoma
According to a recent study published in the American Journal of Otolaryngology, it has been found out that preoperative CT is not reliable for assessment of tumor thickness (TT) in oral tongue squamous cell carcinoma (OTSCC) compared to intraoperative ultrasound (US) and histopathology, particularly for OTSCC under 10 mm.
Byung C.Yoon and colleagues from the Departments of Radiology, Massachusetts General Hospital, Boston, MA, United States of America carried out this present study with the objective to compare the accuracy of oral tongue squamous cell carcinoma (OTSCC) tumor thickness (TT) measured on CT to intraoperative ultrasound (US) and histopathology.
Twenty-six patients with OTSCC who underwent tumor resection by a single surgeon with simultaneous intraoperative US were prospectively identified, and their data reviewed. TT was independently measured in 19 patients who underwent preoperative CT (cTT) by two neuroradiologists blinded to US and histological results.
The confidence level of interpretation of cTT was recorded by each reader using a 5-point Likert scale. The degree of dental artifact on CT was also scored. cTT was compared to TT measured on intraoperative US (uTT) and histopathologic assessment of TT (hTT).
The following results were established-
- OTSCC was visualized on CT in 52% (10/19) and 63% (12/19) of cases for readers 1 and 2, respectively.
- Mean Likert score was 0.42 for reader 1 and 0.73 for reader 2.
- Mean cTT of OTSCCs was 5.8 mm+/−1.7 mm (n = 11).
- In comparison, mean uTT and hTT were 7.6 mm±3.5 mm and 7.1+/− 4.2 mm, respectively.
- The Pearson coefficient (95% confidence interval) was 0.10 (−0.53–0.66) between cTT and hTT (n = 11) and 0.93 (0.74–0.98) between uTT and hTT.
Hence, the authors concluded that "preoperative CT is not reliable for assessment of TT in OTSCC compared to US and histopathology, particularly for OTSCC under 10 mm. US offers a practical complementary imaging tool with a unique role for primary tumor assessment that can aid in pre-operative planning, especially for small tumors."
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd